1 Kalia YN, Guy RH.Modeling transdermal drug release[J]. Adv Drug Deliv Rev, 2001;48:159-172.
2 McCarley KD, Bunge AL.Physiologically relevant two-compartment pharmacokinetic models for skin[J]. J Pharm Sci, 2000; 89: 1212-1235.
3 Sobue S, Sekiguchi K, Kikkawa H, et al.Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch[J]. J Clin Pharmacol, 2005; 45:1391-1399.
4 Rolf C, Kemper S, Lemmnitz G, et al.Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men[J]. Eur J Endocrinol, 2002; 146:673-679.
5 Gupta SK, Hwang S, Southam M, et al.Effects of application site and subject demographics on the pharmacokinetics of fentanyl HCl patient-controlled transdermal system (PCTS)[J]. Clin Pharmacokinet, 2005; 44:25-32.
6 Cusack BJ.Pharmacokinetics in older persons[J]. Am J Geriatr Pharmacother, 2004;2: 274-302.
7 Schwartz JB.The influence of sex on pharmacokinetics[J]. Clin Pharmacokinet, 2003; 42:107-121.
8 Lili C, Shibata N, Yoshikawa Y, et al.Effect of glycerol-induced acute renal failure on the pharmacokinetics of lidocaine after transdermal application in rats[J]. Biol Pharm Bull, 2003;26:1150-1154.
9 Khazaeinia T, Ramsey AA, Tam YK.The effects of exercise on the pharmacokinetics of drugs[J]. J Pharm Pharm Sci, 2000; 3:292-302.
10 Sobue S, Sekiguchi K, Kikkawa H, et al.Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch[J]. J Clin Pharmacol, 2005;45: 1391-1399.
11 Sathyan G, Jaskowiak J, Evashenk M, et al.Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration[J]. Clin Pharmacokinet, 2005; 44:7-15.
12 Weiland L, Croubels S, Baert K, et al.Pharmacokinetics of a lidocaine patch 5% in dogs[J]. J Vet Med A Phy siol Pathol Clin Med, 2006;53:34-39.
13 Ashburn MA, Ogden LL, Zhang J, et al.The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat[J]. J Pain, 2003;4: 291-297.
14 Vanakoski J, Seppala T, Sievi E, et al.Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine[J]. Clin Pharmacol Ther, 1996; 60:308-315.
15 Reginster JY, Donazzolo Y, Brion N, et al.Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women:matrix versus reservoir patches[J]. Climacteric, 2000;3:168-175.
16 MullerM.Science, medicine, and the future: Microdialysis[J]. BMJ, 2002;324:588-591.
17 Anderson C, Andersson T, MolanderM, et al.Ethanol absorption across human skin measured by in vivomicrodialysis technique[J]. Acta Derm Venereol(Stockh),1991;71: 389-393. |
